Patent · US Active

Methods of synthesis and/or purification of diaminophenothiazinium compounds

US10525061B2 · kind B2 · utility

3Cited by
8References
13Claims
0Family size

Inventors

Key dates

Filing dateMay 23, 2018
Grant dateJan 7, 2020
Priority date
Expiry dateMay 23, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (“diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (Methylene Blue), and the resulting high purity characterized by a purity greater than 98%, and very low levels of heavy metals and organic impurities Azure A, B, C and MVB. Also disclosed are methods of treatment of a tauopathy or methemoglobinemia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the high-purity diaminophenothiazinium compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.